Literature DB >> 27789384

Down-regulation of serotonin and dopamine transporter genes in individual rats expressing a gambling-prone profile: A possible role for epigenetic mechanisms.

Francesca Zoratto1, Emilia Romano1, Esterina Pascale2, Mariangela Pucci3, Anastasia Falconi3, Bernardo Dell'Osso4, Mauro Maccarrone5, Giovanni Laviola1, Claudio D'Addario6, Walter Adriani7.   

Abstract

Gambling Disorder (GD) is characterized by excessive gambling despite adverse consequences on individual functioning. In spite of some positive findings, it is difficult to draw any conclusion on the genetics of GD. Indeed, beyond DNA sequence variation, other regulatory mechanisms (like those that engage epigenetics) may explain gene alterations in this addictive disease. Wistar male rats underwent an operant task for the evaluation of individual propensity to gamble. Few rats, after having learnt to prefer nose-poking for a large over a small food reward, were sacrificed to obtain a baseline profile of gene expression at both central and peripheral levels. In the remaining rats, probability of occurrence of large-reward delivery decreased progressively to very low levels. Thus, rats were faced with temptation to "gamble", i.e. to nose-poke for a binge reward, whose delivery was omitted the majority of times. After 3weeks of testing, rats showing a clear-cut profile of either gambling proneness or aversion were selected and sacrificed after the last session. A selective down-regulation of i) serotonin transporter in prefrontal cortex, ii) tyrosine hydroxylase in ventral striatum, iii) dopamine transporter in lymphocytes was evidenced in "gambler" vs "non-gambler" rats. The exposure to such operant task (compared to home-cage alone) modulated ventrostriatal but not prefrontal genes. A consistent increase of DNA methylation, in one specific CpG site at serotonin transporter gene, was evident in prefrontal cortex of "gambler" rats. Elucidation of epigenetic changes occurring during GD progression may pave the way to the development of new therapeutic strategies through specific modulation of epigenetic factors.
Copyright © 2016 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  PBMCs; animal model; dopamine; epigenomics; gambling; lymphocytes; prefrontal cortex; serotonin

Mesh:

Substances:

Year:  2016        PMID: 27789384     DOI: 10.1016/j.neuroscience.2016.10.041

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  3 in total

1.  Potential for diagnosis versus therapy monitoring of attention deficit hyperactivity disorder: a new epigenetic biomarker interacting with both genotype and auto-immunity.

Authors:  Walter Adriani; Emilia Romano; Mariangela Pucci; Esterina Pascale; Luca Cerniglia; Silvia Cimino; Renata Tambelli; Paolo Curatolo; Oleg Granstrem; Mauro Maccarrone; Giovanni Laviola; Claudio D'Addario
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-08-18       Impact factor: 4.785

2.  Activation of 5-HT7 receptor by administration of its selective agonist, LP-211, modifies explorative-curiosity behavior in rats in two paradigms which differ in visuospatial parameters.

Authors:  Cristiana Carbone; Annalisa Adinolfi; Stefano Cinque; Enza Lacivita; Enrico Alleva; Marcello Leopoldo; Walter Adriani
Journal:  CNS Neurosci Ther       Date:  2018-02-01       Impact factor: 5.243

3.  Contribution of Dopamine Transporter Gene Methylation Status to Cannabis Dependency.

Authors:  Anna Grzywacz; Wojciech Barczak; Jolanta Chmielowiec; Krzysztof Chmielowiec; Aleksandra Suchanecka; Grzegorz Trybek; Jolanta Masiak; Paweł Jagielski; Katarzyna Grocholewicz; Blazej Rubiś
Journal:  Brain Sci       Date:  2020-06-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.